New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient or Plavix Presented at TCT - Eli Lilly and Co (NYSE:LLY)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Daiichi Sankyo, Inc. and Eli Lilly andCompany (NYSE: LLY) today announced new results of two retrospective,observational, comparative effectiveness studies of U.S. hospital datacomparing rates of readmission for subsequent heart attack and initialhospitalization costs among patients with acute coronary syndromes (ACS)treated with a percutaneous coronary intervention (PCI) and antiplatelettherapy, including Effient^® (prasugrel) or Plavix^®(clopidogrel). Thefindings were presented at the 24^th annual Transcatheter CardiovascularTherapeutics (TCT) scientific symposium. Sponsored by the CardiovascularResearch Foundation (CRF), TCT is the world's premier educational meetingspecializing in interventional cardiovascular medicine.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!